Company Overview 1509.5.2 Share in the BRICS Dental Implants Market 1519.6 OSSTEM IMPLANT Co. , Ltd. 1529.6.1 Company Overview 1529.6.2 Share in the BRICS Dental Implants Market 1539.7 Southern Implants Inc. 1549.7.1 Company Overview 1549.7.2 Share in the...

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry,...

Ind. , Feb. 13, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the Barclays Capital 2012 Global Healthcare Conference at the Loews Miami Hotel in Miami,...

FRANCISCO, Feb. 8, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, today announced the availability of a new patient education application designed for Apple's iPad tablet. The application,...

(NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today announced the availability of personalized surgical cutting guides for partial knee replacement procedures at the American Academy of Orthopaedic Surgeons annual meeting in San...

FRANCISCO, Feb. 8, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, today announced the availability of a new patient education application designed for Apple's iPad tablet. The application,...

FRANCISCO, Feb. 8, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, introduced its new Zimmer® Universal Power System and STABLECUT® line of surgical saw blades at the 2012 American Academy of...

FRANCISCO, Feb. 7, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, and ISTO Technologies, Inc. , an orthobiologics company focused on developing breakthrough products to regenerate and restore...

Holdings, Inc. (NYSE: ZMH) and ISTO Technologies announced a Phase III clinical study to evaluate DeNovo ET Engineered Tissue Graft, an engineered cartilage implant intended to repair cartilage defects in the knee. DeNovo ET Graft is being developed...

The scenario, however, improves for the second half and onwards. Zimmer reported an adjusted EPS of $1.36 during the fourth quarter of fiscal 2011, up 7.1% year over year and a couple of cents ahead of the Zacks Consensus Estimate. During the reported...

It has two segments: Orthopaedic Implants and MedSurg Equipment. The full research report on Stryker Corporation (NYSE: SYK) is available here: www.BrightonMarkets.com/index.php?coa=SYK. Brighton Markets has released research on Zimmer Holdings, Inc....

Garry Clark, Zimmer spokesman, expressed support for the deal that calls for medical device manufacturers to pay the Food and Drug Administration more in exchange for faster approvals. Zimmer believes this agreement provides FDA with the resources

Holdings (NYSE: ZMH) was downgraded by UBS AG (NYSE: UBS) from a “buy” rating to a “neutral” rating in a research note issued on Wednesday. Separately, analysts at Piper Jaffray (NYSE: PJC) upgraded shares of Zimmer Holdings from a “neutral” rating to...

Goldman Sachs upgrades Citi (NYSE: C) from Neutral to Buy with a price target of $36 (up from $35). Click Here for more color. Piper Jaffray lifts Zimmer Holdings (NYSE: ZMH) from Neutral to Overweight, price target raised from $65 to $75. Goldman Sachs...

Holdings (NYSE: ZMH) was upgraded by research analysts at Piper Jaffray (NYSE: PJC) from a “neutral” rating to an “overweight” rating in a report issued on Monday. Separately, analysts at Jefferies Group (NYSE: JEF) reiterated a “hold” rating on shares...

Holdings (NYSE: ZMH ) reported earnings on Jan. 26. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 31 (Q4), Zimmer Holdings met expectations on revenues and beat expectations on earnings per share. Compared to...

Holdings (NYSE: ZMH)‘s stock had its “sell” rating reiterated by equities research analysts at Goldman Sachs (NYSE: GS) in a research note issued to investors on Friday. Separately, analysts at BMO Capital Markets raised their price target on shares of...

Holdings (NYSE: ZMH)‘s stock had its “hold” rating reaffirmed by equities research analysts at Jefferies Group (NYSE: JEF) in a research note issued to investors on Friday. Separately, analysts at Goldman Sachs (NYSE: GS) reiterated a “sell” rating on...

Over the same time period, Bruno Melzi has purchased no shares of Zimmer Holdings Inc stock. Bruno Melzi has also performed other transactions including exercise of options , and exercise of options. Let's take a quick, high-level look at insider...